SCHEMBL20380508

SCHEMBL20380508

CCCSSCCOC(=O)c1ccc(O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.70
▸ TSHR P16473 3/20 0.70
▸ ALDH1A1 P00352 3/20 0.70
▸ CHRM1 P11229 1/20 0.70
▸ SLC6A2 P23975 1/20 0.70
▸ KDR P35968 1/20 0.70
▸ TDP1 Q9NUW8 1/20 0.70
▸ LMNA P02545 4/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.66
▸ CYP1A2 P05177 2/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ CYP2C19 P33261 2/20 0.66
▸ CYP2D6 P10635 2/20 0.66
▸ NR1H2 P55055 1/20 0.66
▸ RNASEL Q05823 1/20 0.66
▸ ESR2 Q92731 2/20 0.59
▸ CA12 O43570 2/20 0.59
▸ CA1 P00915 2/20 0.59
▸ CA2 P00918 2/20 0.59
▸ CA7 P43166 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylparaben SCHEMBL429594 0.83 ESR1 (1.00) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL977 0.83 ESR1 (1.00) ESR1TSHRALDH1A1CHRM1SLC6A2
SCHEMBL20380504 0.82 RAB9A (0.48) ESR1TSHRALDH1A1CHRM1SLC6A2
SCHEMBL15951668 0.82 ESR1 (0.54) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL9406450 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL1010568 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL5671589 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL37112 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL6315856 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2
Propylparaben SCHEMBL8779117 0.81 ESR1 (0.96) ESR1TSHRALDH1A1CHRM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023555-B2 NSAIDs derivatives and uses thereof RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2018-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023555-B2 NSAIDs derivatives and uses thereof PTGES, PTGES3, PTGS1 ESR1 4383/4885TSHR 4747/4885ALDH1A1 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback